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A B S T R A C T
During the last three decades scientists worldwide have investigated how ultraviolet radiation (UVR) influences the
immune system. The vast majority of the researchers was primarily focused on the local immunomodulatory role of
UVR. But today evidence is increasing in favor of plural immune activation and systemic reaction of the organism. Most
of the attention is directed toward the regulatory T lymphocytes which are responsible for the local and systemic immu-
nosuppressive response under the impact of sunlight. The role of regulatory T cells in autoimmune diseases is well stud-
ied on patients with systemic lupus erythematosus (SLE). Epidemiological research shows a proportional interdepen-
dence of latitude and prevalence of autoimmune diseases such as multiple sclerosis (MS), insulin-dependent diabetes
mellitus (IDDM) and rheumatoid arthritis (RA). There is evidence that UVR has direct influence on the level of antibod-
ies against the SNF2-superfamily helicase (Mi-2), distinctive for dermatomyositis (DM). On this basis a hypothesis is es-
tablished that UVR is a risk factor for DM. A Croatian epidemiologic study of systemic sclerosis (SSc) gave results con-
sistent with the hypothesis that there is a higher prevalence of SSc in the Mediterranean regions of Croatia. Such
discoveries encouraged further studies that found that not only regulatory T cells are responsible for a systemic immu-
nosuppressive response, but that there is a complex interactive network of immune cells and mediators such as cytokines,
neuropeptides, and chromophores like urocanic acid involved. Present findings require continued research on the impor-
tance of UVR on autoimmune disease prevalence and immunopathophysiology. Finally, it is necessary to distinguish
whether UVR is a protective factor for some autoimmune diseases or a risk factor for their induction.
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Introduction
Accumulating evidence suggests that autoimmune di-
seases result from environmental exposures in geneti-
cally predisposed individuals. Environmental triggers for
most autoimmune disorders are poorly understood, al-
though selected infections, drugs, foods, and occupa-
tional exposures have been associated with the onset of
certain immune-mediated syndromes1. Most researchers
agree that a degree of natural autoimmunity in the ab-
sence of disease is needed for the development of effec-
tive immune responses against infectious agents or can-
cer cells. However, individuals with suitable genetic back-
ground and after exposure to certain environmental trig-
gers (such as UVR) may develop an exaggerated immune
response against self, leading to the development of sev-
eral autoimmune diseases, such as RA and SLE. An
environmental exposure of increasing interest in the
pathogenesis of immune-mediated disorders is UVR.
UVR, beyond inducing accelerated skin aging and skin
cancer, has a number of immunomodulatory effects2. It
triggers cytokine production, regulates surface expres-
sion of adhesion molecules, affects cellular mitosis, and
induces apoptotic cell death3. UVR may also alter the ex-
pression of, cellular location of, or immune responses to
auto antigens4. Although little is known about the role of
UVR in the development of autoimmune diseases, it has
been associated with the development of some disorders
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and is known to increase the clinical expression of condi-
tions characterized by photosensitive rashes, such as
SLE and DM5. The mechanisms by which it has these ef-




In the last 30 years numerous studies in the field of
photoimmunology have tried to identify how UVR, in
particular the UVB range, induces immunosuppression.
It is now known that immune suppressive effects of solar
radiation are mediated mostly by middle wave length
range (UVB, 290–320 nm), but recent evidence suggests
that long wave range (UVA, 320–400 nm) can also affect
the immune system.
UV-induced immunosuppression is a highly complex
process in which several different pathways are involved.
UVB does not cause general but rather specific immu-
nosuppression; it inhibits immune reactions in an anti-
gen-specific fashion6. UVR from the sun causes DNA
damage to Langerhans cells (LCs) and keratinocytes,
causing the damaged LC to migrate to lymph nodes with
antigen6–8. UVR also causes trans to cis isomerisation of
urocanic acid and lipid peroxidation9. This leads to pro-
duction of multiple immunoregulatory factors in the epi-
dermis, including interleukin-10 (IL-10), tumor necrosis
factor, platelet-activating factor, and prostaglandin E210–12.
UV also causes infiltration into the dermis of IL-10 se-
creting macrophages, the release of histamine from mast
cells and the activation of B lymphocytes into suppressor
B cells in draining lymph nodes13–15. In the lymph nodes,
interactions between the antigen presenting cells, dam-
aged LC, lymph node dendritic cell and suppressor B
lymphocytes results in the activation of regulatory T
cells (Treg), which than suppress skin immunity. Activa-
tion of UV-induced Treg (UV-Treg) is antigen specific,
but when suppression is once activated it becomes non-
specific (bystander suppression), meaning that UV-Treg
suppress immune responses in a general fashion via the
release of IL-10. UV-Treg, which suppress hapten medi-
ated contact hypersensitivity, express CD4, CD25, and
CTLA-4, and may use the apoptosis-related Fas/Fas-li-
gand system and secrete IL-10 upon hapten specific
stimulation16.
Finally, we can conclude that UVB-induced DNA da-
mage is a major molecular trigger of UV-mediated immu-
nosuppression. Recent gene expression analysis of chan-
ges induced by UVR in dendritic cells (DC) showed up-re-
gulated expression of genes involved in cellular stress
and inflammation, and down-regulated genes involved in
chemotaxis, vesicular transport and RNA processing.
These results indicate that UV-exposure triggers the reg-
ulation of a complex gene repertoire involved in hu-
man-DC-mediated immune response17. Reduction of DNA
damage mitigates UV-induced immunosuppression. Li-
kewise, interleukin-12 which exhibits the capacity to re-
duce DNA damage can prevent UV-induced suppression
and even break tolerance7.
UVR and Autoimmune Diseases
Polymorphic light eruption (PLE) is the most com-
mon photodermatosis, with the prevalence of 10–20% in
the European population18,19. Recent evidence indicates
that PLE patients are resistant to the immune suppres-
sive effects of sunlight mentioned before, a phenomenon
that leads to the formation of skin lesions upon sun expo-
sure. In patients with PLE, a persistence of LCs and fail-
ure of UV-induced immune suppression may favor the
occurrence of autoimmunogenic skin rashes. Exposure to
UVB leads to the decreased neutrophil infiltration into
the skin of PLE patients compared with healthy subjects.
This lack of neutrophil infiltration is associated with im-
paired IL-4 and IL-10 release, suppressed macrophage
infiltration and LC resistance, resulting in non-suppres-
sive microenvironment in the skin. In normal subjects,
on the other hand, concurrent UV-induced immunosup-
pression may prevent autoimmunity and, therefore, the
formation of the skin rashes upon UV exposure20. Inter-
estingly, it was recently found that females are more re-
sistant to the immunosuppressive effects of UVR and it
is suggested that this phenomenon is may be due the ex-
pression of the estrogen receptor. This may explain why
PLE is more common in females and why the risk de-
creases in woman after the menopause21.
Systemic lupus erythematosus (SLE) represents an
autoimmune disease with great clinical variability in
which photosensitivity is a common feature for all forms
and subsets22. Photosensitivity is one of the diagnostic
criteria of systemic lupus erythematosus, suggesting an
important role of UVR in the pathogenesis of SLE. Many
different studies show that SLE is characterized by apo-
ptosis of keratinocytes and an inflammatory infiltrate of
the skin (which consists of skin infiltrating memory T
lymphocytes and the majority of these cells display CD4
phenotype). Also we can find that UVR is a trigger of
apoptosis in keratinocytes and there is evidence in exper-
imental animals that an abnormality in the generation
and clearance of apoptotic material is an important sour-
ce of antigens in autoimmune diseases (in »normal« skin
these apoptotic keratinocytes are usually cleared within
48 hours after sunburn), but this findings in humans still
remains controversial23–25. It is not yet possible to con-
clude if lupus photosensitivity is caused by an aberrant
response of keratinocytes to UV injury, a defective clear-
ance of apoptotic cells or an abnormal immune response
to these cells, but photo protection is still essential in the
treatment of lupus patients.
Dermatomyositis (DM) is an autoimmune disease, a
form of idiopathic inflammatory myopathy, strongly as-
sociated with the development of disease-specific auto
antibodies directed against the SNF2-superfamily he-
licase, Mi-2. DM is distinguishable from polymyositis
(PM) by the occurrence of photosensitive skin rashes26.
Recent evidence suggest that exposure to UVRmay be an
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important risk factor for the disease as well as the devel-
opment of Mi-autoimmunity. A study investigating glo-
bal surface UV intensity and the development of DM
showed a statistically significant association of UV inten-
sity with the frequency of disease and even more inter-
esting was a similar relationship between UV intensity
and DM patients expressing Mi-2 auto antibodies27. Burd
et al. observed an increase in the Mi-2 protein expression
upon UVR exposure in cell culture system28. This data
supports the mechanism of UV-induced DM-specific auto-
immunity in the immune targeting of Mi-2.
Systemic sclerosis (SS). Epidemiological evidence for
the association between environmental and occupational
risk factors and systemic sclerosis (SSc) has been exten-
sively analyzed. Environmental factors could be classi-
fied as occupational (silica, organic solvents), infectious
(bacterial, viral), and non-occupational/non-infectious
(drugs, pesticides, silicones)29. Understanding of the link
between environmental risk factors and the development
of SSc is limited, due to the phenotypic and pathogenic
heterogeneity of patients and disease. Recently, a Cro-
atian epidemiologic study of SSc gave results consistent
with the hypothesis that UVR intensity is a risk factor
for this disease. Evidence showed that there is a higher
prevalence of SSc in the Mediterranean regions of Cro-
atia. This data supports the mechanism of UV-induced
autoimmunity in SSc, but are opposite to results that
show that UVA-1 treatment can shorten the active pe-
riod of localized scleroderma and pseudoscleroderma and
prevent further disease progression, including contra-
ctures30.
Vasculitis. One ecological study published this year
describes and quantifies the association between ambi-
ent UVR levels, including daily winter vitamin D effec-
tive UVR levels and the incidence of the 3 antineutrophil
cytoplasmic antibody-associated vasculitides: Wegeners
granulomatosis (WG), microscopic polyangiitis (MPA),
and Churge-Strauss syndrome (CSS). Results show that
the incidence of WG and CSS increased with increasing
latitude and decreasing ambient UVR, with a stronger
and more consistent effect across different UVR mea-
sures for WG. There was no apparent latitudinal varia-
tion in MPA incidence. These findings are consistent
with protective immunomodulatory effect of ambient
UVR on the onset of WG and CSS31.
Multiple sclerosis (MS), Type I Diabetes (IDDM), and
Rheumatoid arthritis (RA). Recent works suggest that
UVR exposure may have a possible beneficial role on
these three Th-1 mediated autoimmune diseases32. One
of the most striking epidemiological features of MS is a
gradient of increasing prevalence with higher latitude.
Such gradient has been reported in Europe and USA33.
However, there has not been a causal association found.
Increased dietary intake and increased serum levels of vi-
tamin D showed to be protective for the development of
MS. UVR plays an important role in vitamin D synthesis
and could potentially explain both latitude differences
and low levels of vitamin D in individuals with MS34. The
prevalence of IDDM has been increasing worldwide over
the past two decades. There is considerable variation in
incidence of IDDM, for example, in Europe the incidence
increases with increasing latitude35. Several studies have
reported that vitamin D supplementation is associated
with a reduced risk of IDDM36. RA is chronic multi-
system inflammatory disease for which a clear latitudi-
nal gradient has not been established to the same extent
as for MS and IDDM37.
Conclusions
Presented findings require continued investigation of
the influence of UVR on the autoimmune diseases occur-
rence and immunopathophysiology. Finally, it is neces-
sary to distinguish whether UVR is a protective factor for
some autoimmune diseases or a risk factor for their in-
duction.
It is obvious that UVR at low doses suppresses the im-
mune response. We can speculate that a certain degree of
immunosuppression may be beneficial by preventing the
induction of these autoimmune diseases.
The findings summarized in this review highlight the
critical importance of considering the benefits as well as
the adverse effects of UVR for wide range outcomes in
autoimmune diseases when formulating public health
policy on UVR exposure. It is necessary to provide infor-
mation on the minimum sun exposure required for bene-
ficial health effects and maximum sun exposure to avoid
the adverse effects associated with sun exposure. Fur-
ther investigation is required to assess the correct titra-
tion of human exposure to ambient UVR for optimal im-
mune function and overall health38.
The achievements in photoimmunology over the last
years have not only expanded our knowledge of how UVR
influences the immune system but also gave us impor-
tant insights into general immunology. Therefore further
studies will not only increase our understanding how
UVR acts as a pathogen but will also support the develop-
ment of new therapeutic strategies, like suppressing au-
toimmune reactions via administration of antigen-spe-
cific regulatory T cells.
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UTJECAJ UV ZRA^ENJA NA IMUNOLO[KI SUSTAV I POJAVNOST AUTOIMUNIH BOLESTI
S A @ E T A K
Unazad tri desetlje}a znanstvenici diljem svijeta istra`uju utjecaj ultraljubi~astog (UV) zra~enja na imunolo{ki sus-
tav. Velik dio istra`ivanja je bio usmjeren prvenstveno na lokalnu imunomodulatornu ulogu UV zra~enja. No danas sve
vi{e studija pokazuje da uslijed UV zra~enja dolazi do vi{estruke aktivacije imunog sustava sa sistemskom reakcijom
organizma. Do sada je najvi{e pa`nje posve}eno regulacijskim T limfocitima koji su odgovorni za lokalni i sustavni
imunosupresijski odgovor pod utjecajem sun~evog zra~enja. Primjerice, uloga regulacijskih T limfocita u autoimunim
bolestima dobro je prou~ena kod sistemskog lupusa eritematosusa. Epidemiolo{ke studije pokazuju da postoji propor-
cionalna me|uovisnost izme|u zemljopisne {irine i pojavnosti autoimunih bolesti poput multiple skleroze, dijabetesa
ovisnog o inzulinu te reumatoidnog artritisa. S druge strane, postoje dokazi da UV zra~enje izravno utje~e na razinu
protutijela protiv SNF2-superfamilije helikaza (Mi-2) koja su specifi~na za dermatomiozitis. Tako je postavljena hipo-
teza o UV zra~enju kao rizi~nom faktoru za oboljele od dermatomiozitisa. Hrvatska epidemiolo{ka studija o sistemskoj
sklerozi dala je rezultate konzistentne s potonjom hipotezom; u mediteranskim krajevima Hrvatske zabilje`ena je ve}a
prevalencija. Ovakva otkri}a potaknula su daljnja istra`ivanja, kojima se otkriva da nemaju samo regulacijski T lim-
fociti ulogu u sustavnom imunosupresijskom odgovoru tijela, ve} postoji kompleksna mre`a me|udjelovanja imunih
stanica i medijatora: citokina, neuropeptida te kromofora poput urokanske kiseline. Dosada{nje spoznaje zahtijevaju
daljnja istra`ivanja o povezanosti pojavnosti i imunopatofiziologije autoimunosnih bolesti sa UV zra~enjem. Tako|er
treba razlu~iti ima li UV zra~enje u kona~nici za{titnu ulogu kod nekih autoimunih bolesti ili je faktor rizika za pojavu
istih.
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